Associate Chief Physician. Specialties: Diagnosis and treatment of urological tumors including renal tumor, prostate cancer, bladder cancer, and urinary tract stone diseases. Proficient in minimally‑invasive surgeries such as laparoscopy, ureteroscopy and cystoscopy.He once studied as a visiting scholar at the Cleveland Clinic. In recent years, he has conducted research on the immune microenvironment and drug resistance of renal cell carcinoma. He has presided over projects of the National Natural Science Foundation of China and projects of the Shanghai Municipal Health Commission. He has published more than 30 SCI papers as the first author or corresponding author. "Establishment of a Precision Minimally‑Invasive Diagnosis and Treatment System for Renal Cell Carcinoma" won the Second Prize of Shanghai Science and Technology Progress Award (3rd completer) and the Second Prize of Shanghai Medical Science and Technology Award (3rd completer). He was honored as "2019 Young Outstanding Talent" selected by the Shanghai Urological Medical Association. Based on data from the Global Scholars Database, he was named a Chinese scholar with high academic influence in the field of urology in 2020.